R. Mineo

发表

Androgens Upregulate the Insulin-like Growth Factor-I Receptor in Prostate Cancer Cells

C. Roberts, A. Belfiore, F. Frasca, 2005 .

Receptor in Prostate Cancer Cells Androgens Upregulate the Insulin-like Growth Factor-I Updated

C. Roberts, A. Belfiore, F. Frasca, 2005 .

Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.

C. Roberts, A. Belfiore, F. Frasca, 2005, Cancer research.

Promoter usage for insulin-like growth factor-II in cancerous and benign human breast, prostate, and bladder tissues, and confirmation of a 10th exon.

Y. Fujita-Yamaguchi, R. Mineo, E. Fichera, 2000, Biochemical and biophysical research communications.

A quantitative reverse transcription and polymerase chain reaction assay for human IGF-II allows direct comparison of IGF-II mRNA levels in cancerous breast, bladder, and prostate tissues.

Y. Fujita-Yamaguchi, R. Mineo, E. Fichera, 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A

A. Belfiore, G. Pandini, L. Sciacca, 2002, Oncogene.

Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels.

A. Costantino, A. Belfiore, L. Sciacca, 2004, Endocrinology.

Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism

A. Costantino, A. Belfiore, F. Frasca, 1999, Oncogene.

The IGF system in thyroid cancer: new concepts

A. Belfiore, G. Pandini, L. Sciacca, 2001, Molecular pathology : MP.

The role of insulin-like growth factor-II in cancer growth and progression evidenced by the use of ribozymes and prostate cancer progression models.

R. Sikes, Shu-lian Li, Jingwen Ye, 2003, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Insulin Receptor Isoform A, a Newly Recognized, High-Affinity Insulin-Like Growth Factor II Receptor in Fetal and Cancer Cells

A. Costantino, A. Belfiore, F. Frasca, 1999, Molecular and Cellular Biology.

A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer.

A. Belfiore, G. Pandini, L. Sciacca, 2002, The Journal of clinical endocrinology and metabolism.

Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity.

P. Vigneri, A. Costantino, A. Belfiore, 1996, Molecular endocrinology.

ACTIVATION OF THE HGF / MET SYSTEM IN PAPILLARY THYROID CANCER: BIOLOGICAL EFFECTS OF HGF IN THYROID CANCER CELLS DEPEND ON MET EXPRESSION LEVELS

Riccardo, A. Costantino, A. Belfiore, 2004 .

Insulin/Insulin-like Growth Factor I Hybrid Receptors Have Different Biological Characteristics Depending on the Insulin Receptor Isoform Involved*

A. Belfiore, F. Frasca, G. Pandini, 2002, The Journal of Biological Chemistry.

Interleukin-4 stimulates papillary thyroid cancer cell survival: implications in patients with thyroid cancer and concomitant Graves' disease.

E. Mazzon, A. Belfiore, F. Frasca, 2004, The Journal of clinical endocrinology and metabolism.

Interleukin-1 blocks insulin and insulin-like growth factor-stimulated growth in MCF-7 human breast cancer cells by inhibiting receptor tyrosine kinase activity.

A. Costantino, A. Belfiore, F. Frasca, 1996, Endocrinology.